Some studies have shown that the burden of JAK2 V617F alleles can correlate with the phenotypic presentation of MPN [13], severity of the disease phenotype [14], risk of thrombotic events [15], progression to post-PV myelofibrosis, and survival [6,16]. This evidence concerns the gene JAK2 and acquired polycythemia vera.